Bayer Schering Partners With Polish Biotech Firm To Provide Recombinant Insulin To China's Exploding Diabetics Population

BEIJING - The heads of Germany's Bayer Schering Pharma AG and the Polish biotech firm Bioton, which produces human recombinant insulin, met in the Chinese capital this week to sign an agreement that sets the stage for Bayer to market the biopharmaceutical SciLin across China